This is consistent with a recent paper reporting that prostate cancer expressed higher levels of Ldha and phosphorylated Ldha, and lower levels of Ldhb, than normal tissue, and that a high Ldha/Ldhb ratio was a marker of poor clinical prognosis [41]. This evidence concerns the gene LDHA and prostate cancer.